What is Gilead Sciences's u.s. — total revenues?

Gilead Sciences (GILD) reported u.s. — total revenues of $4.93B in Q1 2026.

How has Gilead Sciences's u.s. — total revenues changed year-over-year?

Gilead Sciences's u.s. — total revenues increased by 5.5% year-over-year, from $4.67B to $4.93B.

What is the long-term trend for Gilead Sciences's u.s. — total revenues?

Over 4 years (2021 to 2025), Gilead Sciences's u.s. — total revenues has grown at a 2.0% compound annual growth rate (CAGR), from $19.27B to $20.88B.

Geographic · Total revenues

U.S. — Total revenues

Gilead Sciences U.S. — Total revenues decreased by 16.2% to $4.93B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.5%, from $4.67B to $4.93B. Over 4 years (FY 2021 to FY 2025), U.S. — Total revenues shows relatively stable performance with a 2.0% CAGR.

Analysis

StatementSegment

First reportedQ1 2016

Last reportedQ1 2026May 7, 2026

Rolls up toTotal Revenue

Metric ID: gild_segment_u_s_total_revenues

Historical Data

20 periods

	Q2 '21	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$4.23B	$5.51B	$5.27B	$4.36B	$4.34B	$4.93B	$5.26B	$4.45B	$4.78B	$5.02B	$5.19B	$4.63B	$4.94B	$5.45B	$5.57B	$4.67B	$5.05B	$5.28B	$5.88B	$4.93B
QoQ Change	—	+30.1%	-4.4%	-17.3%	-0.4%	+13.6%	+6.8%	-15.4%	+7.5%	+4.9%	+3.3%	-10.6%	+6.6%	+10.3%	+2.1%	-16.1%	+8.2%	+4.6%	+11.3%	-16.2%
YoY Change	—	—	—	—	+2.5%	-10.5%	-0.1%	+2.2%	+10.3%	+1.8%	-1.5%	+4.1%	+3.3%	+8.6%	+7.4%	+0.8%	+2.2%	-3.1%	+5.6%	+5.5%

Range$4.23B – $5.88B

CAGR+3.2%

Avg YoY Growth+2.4%

Median YoY Growth+2.4%

Frequently Asked Questions

What is Gilead Sciences's u.s. — total revenues?: Gilead Sciences (GILD) reported u.s. — total revenues of $4.93B in Q1 2026.
How has Gilead Sciences's u.s. — total revenues changed year-over-year?: Gilead Sciences's u.s. — total revenues increased by 5.5% year-over-year, from $4.67B to $4.93B.
What is the long-term trend for Gilead Sciences's u.s. — total revenues?: Over 4 years (2021 to 2025), Gilead Sciences's u.s. — total revenues has grown at a 2.0% compound annual growth rate (CAGR), from $19.27B to $20.88B.